The boards of JPMorgan Elect and JPMorgan Global Growth and Income have signed Heads of Terms in respect of a proposed merger of the two companies. The merger will be effected by way of a scheme of reconstruction of Elect. It is expected that the combination will be completed by the end of the current calendar […]
In QuotedData’s morning briefing 27 October 2022: Taylor Maritime Investments (TMI) is reporting a fall in its NAV which at 30 September 2022 was $1.70, a decrease of about 5% since 30 June 2022. The market value of the vessel portfolio at the quarter end was $447m, down about 15% on a like-for-like basis over […]
In QuotedData’s morning briefing 26 October 2022: Oakley Capital Investments (OCI) generated a 4% return on NAV over the quarter ended 30 September 2022 as its underlying portfolio of tech-enabled companies continued to deliver earnings growth. New investments of £46m included the acquisition of vLex, an additional investment in Grupo Primavera, and supporting TechInsights’ acquisition […]
VinaCapital Vietnam Opportunity Fund reports that, for the 12 months ended 30 June 2022, its NAV total return in US dollar terms was -8.8%. The shares fell by 12.8% in US dollar terms as the discount widened from 17.7% to 19.8%, but the dividend was increased from 11.5 cents to 16 cents per share. The […]
In QuotedData’s morning briefing 25 October 2022: VH Global Sustainable Energy Opportunities (GSEO) has completed its purchase of three fully-permitted solar PV sites in Australia. The total cost including construction will be £21.2m and is part of the existing £50m commitment to its Australian solar PV and storage investment programme. Triple Point Energy Transition (TENT) […]
BioPharma Credit has, together with BioPharma Credit Investments V (Master) LP, entered into a senior secured loan agreement with Insmed Incorporated. The company invested US$140m and BioPharma-V invested an additional US$210m. BioPharma Credit only put up 40% because it needed to hold cash to fund its discount control mechanism. Based in the US, Insmed is […]
In QuotedData’s morning briefing 20 October 2022: Riverstone Credit Opportunities (RCOI) says that its NAV rose by 7% over the third quarter of 2022, hitting $1.10. The major driver was Seawolf Water Resources but the fund also realised its investment in FS Crude LLC, crystallising a 14.8% gross IRR and a 1.23x gross MOIC; Circulus Holdings […]
HICL Infrastructure does not plan to publish its interim results until 23 November 2022. However, it is publishing an estimate of its end September NAV today and, given the economic and political backdrop, it is not bad news. The board expects to announce a moderate increase in the unaudited NAV of 1.2p to 164.3p. The […]
In QuotedData’s morning briefing 18 October 2022: Tufton Oceanic Asssets (SHIP) says that its end September NAV was $1.479 (132.5p), giving investors a return for the third quarter of 3.3% on NAV. The target annual dividend is being increased from $0.080 to $0.085 per share, to commence from 4Q22. After the increase, the company is […]
abrdn Asia Focus says that, for the year ended 31 July 2022, it generated an NAV return of -2.0% and a share price return of -1.7%, both ahead of the -5.1% return on the MSCI Asia ex Japan Small Cap Index. The dividend was upped from 3.2p to 8.0p and this was covered by revenue […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
